The pan-PIM inhibitor PIM447 enhances the antitumor activity of lenalidomide in multiple myeloma cells via synergistic inhibition of c-MYC

被引：2
|
作者：
Hao, Huaixiang
Wang, Dannie
Vanasse, Gary
Caponigro, Giordano
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4630
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4630
引用
收藏
页数：4
相关论文
共 21 条
  • [1] Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma
    Paino, Teresa
    Gonzalez-Mendez, Lorena
    San-Segundo, Laura
    Corchete, Luis A.
    Hernandez-Garcia, Susana
    Diaz-Tejedor, Andrea
    Algarin, Esperanza M.
    Mogollon, Pedro
    Martin-Sanchez, Montserrat
    Gutierrez, Norma C.
    Mateos, Maria-Victoria
    Garayoa, Mercedes
    Ocio, Enrique M.
    [J]. CANCERS, 2020, 12 (10) : 1 - 20
  • [2] The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
    Marc S. Raab
    Sheeba K. Thomas
    Enrique M. Ocio
    Andreas Guenther
    Yeow-Tee Goh
    Moshe Talpaz
    Nicolas Hohmann
    Sylvia Zhao
    Fang Xiang
    Carl Simon
    K. Gary Vanasse
    Shaji K. Kumar
    [J]. Leukemia, 2019, 33 : 2924 - 2933
  • [3] The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma
    Raab, Marc S.
    Thomas, Sheeba K.
    Ocio, Enrique M.
    Guenther, Andreas
    Goh, Yeow-Tee
    Talpaz, Moshe
    Hohmann, Nicolas
    Zhao, Sylvia
    Xiang, Fang
    Simon, Carl
    Vanasse, K. Gary
    Kumar, Shaji K.
    [J]. LEUKEMIA, 2019, 33 (12) : 2924 - 2933
  • [4] THE PAN-PIM KINASE INHIBITOR, PIM447, POTENTLY SYNERGIZES WITH POMALIDOMIDE PLUS DEXAMETHASONE IN PRECLINICAL IN VITRO AND IN VIVO MODELS OF MULTIPLE MYELOMA
    Paino, T.
    San-Segundo, L.
    Hernandez-Garcia, S.
    Gonzalez-Mendez, L.
    Algarin, E. M.
    Martin-Sanchez, M.
    Mateos, M. -V.
    Garayoa, M.
    Ocio, E. M.
    [J]. HAEMATOLOGICA, 2017, 102 : 501 - 501
  • [5] THE PAN-INHIBITOR OF PIM KINASES, PIM447, POWER THE EFFECT OF POMALIDOMIDE AND DEXAMETASONE IN MULTIPLE MYELOMA
    Paino, T.
    San Segundo, L.
    Hernandez Garcia, S.
    Gonzalez Mendez, L.
    Algarin, E. M.
    Lopez Iglesias, A. A.
    Mogollon, P.
    Martin Sanchez, M.
    Diaz Tejedor, A.
    Gutierrez, N.
    Mateos, M. V.
    Garayoa, M.
    Ocio Enrique, M.
    [J]. HAEMATOLOGICA, 2017, 102 : 3 - 4
  • [6] Concurrent Inhibition of Pim and Akt Pathways with Pim447 and Afuresertib Activates FOXO3a and Depletes c-Myc to Induce Synergistic Cell Death in Multiple Myeloma
    Keane, Niamh
    Reidy, Mairead
    Natoni, Alessandro
    O'Dwyer, Michael
    [J]. BLOOD, 2015, 126 (23)
  • [7] PRECLINIC EVALUATION OF PAN-INHIBITOR OF PIM-KINASAS, PIM447 IN THE BONE DISEASE ASSOCIATED WITH MULTIPLE MYELOMA
    Esperanza Macarena, Algarin
    Teresa, Paino
    Antonio, Garcia-Gomez
    Laura, San-Segundo
    Montserrat, Martin-Sanchez
    Susana, Hernandez-Garcia
    Ana Alicia, Lopez-Iglesias
    Lorena, Gonzalez-Mendez
    Enrique M, Ocio
    Mercedes, Garayoa
    [J]. HAEMATOLOGICA, 2016, 101 : 94 - 95
  • [8] The Pan-PIM Kinase Inhibitor LGH447 Shows Activity In PIM2-Dependent Multiple Myeloma and In AML Models
    Garcia, Pablo D.
    Langowski, John L.
    Holash, Jocelyn
    Burger, Matthew
    Zang, Richard
    Zavorotinskaya, Tatiana
    Fanton, Christie
    Saci, Abdel
    Growney, Joseph
    Vanasse, K. Gary
    [J]. BLOOD, 2013, 122 (21)
  • [9] Activity of the pan-PIM kinase inhibitor INCB053914 in models of multiple myeloma
    Koblish, Holly
    Shin, Niu
    Hall, Leslie
    Wen, Xiaoming
    O'Connor, Sybil
    Dostalik, Valerie
    Wang, Qian
    Wang, Kathy
    Covington, Maryanne
    Marando, Cindy
    Bowman, Kevin
    Boer, Jason
    Burke, Krista
    Zhang, Ke
    Feng, Hao
    Xue, Chu-Biao
    Li, Yun-Long
    Yao, Wenqing
    Huber, Reid
    Vaddi, Kris
    Scherle, Peggy
    [J]. CANCER RESEARCH, 2015, 75
  • [10] Phase 1 Study Update of the Novel Pan-Pim Kinase Inhibitor LGH447 in Patients with Relapsed/ Refractory Multiple Myeloma
    Raab, Marc S.
    Ocio, Enrique M.
    Thomas, Sheeba K.
    Guenther, Andreas
    Goh, Yeow-Tee
    Lebovic, Daniel
    Jakubowiak, Andrzej
    Song, Dongweon
    Xiang, F.
    Patel, Apurva
    Vanasse, K. Gary
    Kumar, Shaji
    [J]. BLOOD, 2014, 124 (21)
123